Conference report--protein kinase inhibitors in cancer treatment: mixing and matching? Highlights of the keystone symposium on protein kinases and cancer; February 24-29, 2004; Lake Tahoe, California
- PMID: 15266251
- PMCID: PMC1395807
Item in Clipboard
Conference report--protein kinase inhibitors in cancer treatment: mixing and matching? Highlights of the keystone symposium on protein kinases and cancer; February 24-29, 2004; Lake Tahoe, California
MedGenMed.
.
No abstract available
Similar articles
-
Role of Raf kinase in cancer: therapeutic potential of targeting the Raf/MEK/ERK signal transduction pathway.Semin Oncol. 2006 Aug;33(4):392-406. doi: 10.1053/j.seminoncol.2006.04.002. Semin Oncol. 2006. PMID: 16890795 Review.
-
Recent advances of RAF (rapidly accelerated fibrosarcoma) inhibitors as anti-cancer agents.Eur J Med Chem. 2018 Oct 5;158:144-166. doi: 10.1016/j.ejmech.2018.09.005. Epub 2018 Sep 6. Eur J Med Chem. 2018. PMID: 30216849 Review.
-
Novel aspects of epidermal growth factor receptor in relation to tumor development.FEBS J. 2010 Jan;277(2):300. doi: 10.1111/j.1742-4658.2009.07447.x. Epub 2009 Nov 18. FEBS J. 2010. PMID: 19922470 No abstract available.
-
Epidermal growth factor receptor inhibitors: current status and future directions.Curr Probl Cancer. 2009 Jul-Aug;33(4):245-94. doi: 10.1016/j.currproblcancer.2009.10.002. Curr Probl Cancer. 2009. PMID: 20082842 Review. No abstract available.
-
EGFR tyrosine kinase inhibitors in lung cancer: an evolving story.Annu Rev Med. 2008;59:429-42. doi: 10.1146/annurev.med.59.090506.202405. Annu Rev Med. 2008. PMID: 17716025 Review.
Cited by
-
Staurosporine induces apoptosis in pancreatic carcinoma cells PaTu 8988t and Panc-1 via the intrinsic signaling pathway.Eur J Med Res. 2019 Jan 28;24(1):5. doi: 10.1186/s40001-019-0365-x. Eur J Med Res. 2019. PMID: 30686270 Free PMC article.
-
Marine Sponges and Bacteria as Challenging Sources of Enzyme Inhibitors for Pharmacological Applications.Mar Drugs. 2017 Jun 12;15(6):173. doi: 10.3390/md15060173. Mar Drugs. 2017. PMID: 28604647 Free PMC article. Review.
-
Kinase inhibitors from marine sponges.Mar Drugs. 2011;9(10):2131-2154. doi: 10.3390/md9102131. Epub 2011 Oct 24. Mar Drugs. 2011. PMID: 22073013 Free PMC article. Review.
-
The active role of the transcription factor Sp1 in NFATc2-mediated gene regulation in pancreatic cancer.BMC Biochem. 2019 Jan 29;20(1):2. doi: 10.1186/s12858-019-0105-4. BMC Biochem. 2019. PMID: 30696421 Free PMC article.
References
-
- Wittes R. A clinical perspective on the future of kinase-targeted therapies. Program and abstracts of the Keystone Symposium Protein Kinases and Cancer: The Promise of Molecular Based Therapies; February 24-29, 2004; Lake Tahoe, California.
-
- Giaccone G, Herbst RS, Manegold C, et al. Gefitinib in combination with gemcitabine and cisplatin in advanced non-small-cell lung cancer: a phase III trial--INTACT 1. J Clin Oncol. 2004; 22: 777-784. - PubMed
-
- Herbst RS, Giaccone G, Schiller JH, et al. Gefitinib in combination with paclitaxel and carboplatin in advanced non-small-cell lung cancer: a phase III trial--INTACT 2. J Clin Oncol. 2004; 22: 785794. - PubMed
-
- Arteaga CL. Predictors of response and resistance to ErbB tyrosine kinase inhibitors. Program and abstracts of the Keystone Symposium Protein Kinases and Cancer: The Promise of Molecular Based Therapies; February 24-29, 2004; Lake Tahoe, California.
-
- Arteaga CL. EGF receptor as a therapeutic target: patient selection and mechanisms of resistance to receptor-targeted drugs. J Clin Oncol. 2003;21(23 suppl):289s-291s. J Clin Oncol. 2003; 21 (23suppl): 289s-291s. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
